BioElectronics' ActiPatch® Musculoskeletal Pain Therapy Now Available in Boots Stores

FREDERICK, Md., Dec. 9, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that Boots (, the UK's premier health and beauty retailer, is selling its ActiPatch® Pain Therapy products in its select stores for back, knee and musculoskeletal ailments.  

Paul Screawn, Director of GRO-International, European Brand Managers, said "ActiPatch® brings real innovation to both consumers and customers. The innovation and the consumer benefits of long lasting, safe and affordable pain relief gained the interest of the Boots team.  Their input and guidance has been invaluable in ensuring the Brand is relevantly positioned to grow in the UK and broader European markets.  We are looking forward to working together to safely relieve pain, inflammation, and accelerate healing at affordable prices on current and our pipeline of new products."

About Alliance Boots
Boots is a leading pharmacy group in the United Kingdom, part of the Boots Alliance in more than 25 countries, and is a strategic partner with Walgreens Co., the largest drugstore chain in the United States.

For more information, please contact the Boots UK Press Office on 020 7025 6657 or

About BioElectronics Corporation
BioElectronics Corporation is the maker of disposable, drug-free, pain therapy medical devices.  ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; and the Allay® Menstrual Pain Therapy.

Please visit for more information.

Paul Knopick

SOURCE BioElectronics Corporation


More by this Source

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.